Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019381 · ClinicalTrials.gov registry record · NA
Study the Effects of Vitamin D and Calcium Supplementation at Tolerable Upper Limit Doses on Calcium Metabolism.
A NA study, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT02019381: Completed NA study, sponsored by Winthrop University Hospital.
NCT02019381 is a NA study that has completed, run by Winthrop University Hospital. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019381, a NA study, has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
Recently two distinguished committees, Institute of Medicine (IOM) and The Endocrine Society have proposed different intake guidelines for Calcium and Vitamin D. We wish to compare the effects of both of them on calcium metabolism and bone turnover. We propose a one year randomized double blinded study for the same.
Primary Outcome
Endocrine society has recommended tolerable upper limit or a dose with no adverse events as 10,000IU of Vitamin D and 2000 mg/day of calcium. Our study will test the safety/ efficacy of this recommendation.
Interventions
- DIETARY_SUPPLEMENT Calcium
- DIETARY_SUPPLEMENT Endocrine Society UL Dosage Vitamin D
- DIETARY_SUPPLEMENT Institute of Medicine Dosage Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02019381 record still lists
NCT02019381 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Calcium is the first listed.
NCT02019381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02019381 about?
NCT02019381 is a clinical study titled "Study the Effects of Vitamin D and Calcium Supplementation at Tolerable Upper Limit Doses on Calcium Metabolism.". Recently two distinguished committees, Institute of Medicine (IOM) and The Endocrine Society have proposed different intake guidelines for Calcium and Vitamin D. We wish to compare the effects of both of them on calcium metabolism and bone turnover. We propose a one year randomized double blinded st...
What is the current status of trial NCT02019381?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2013-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02019381?
The interventions under investigation include: Calcium (DIETARY_SUPPLEMENT), Endocrine Society UL Dosage Vitamin D (DIETARY_SUPPLEMENT), Institute of Medicine Dosage Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02019381?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02019381's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia